• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Ag Ord (OP:BAYZF)

31.07 +0.32 (+1.04%)
Streaming Delayed Price Updated: 1:12 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,520
Open 31.07
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 30.75
Today's Range 31.07 - 31.07
52wk Range 19.50 - 34.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
October 24, 2025
From Bayer
Via Business Wire
Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
October 21, 2025
From Bayer
Via Business Wire

Performance

YTD
+57.7%
+57.7%
1 Month
-8.8%
-8.8%
3 Month
-2.5%
-2.5%
6 Month
+13.0%
+13.0%
1 Year
+14.1%
+14.1%

More News

Read More
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
October 07, 2025
From Bayer
Via Business Wire
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
October 07, 2025
From Bayer
Via Business Wire
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
October 07, 2025
From Bayer
Via Business Wire
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
September 29, 2025
From Bayer
Via Business Wire
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
September 25, 2025
From Bayer
Via Business Wire
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
September 22, 2025
From Bayer
Via Business Wire
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
September 15, 2025
From Bayer
Via Business Wire
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
August 27, 2025
From Bayer
Via Business Wire
Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
August 18, 2025
From Bayer
Via Business Wire
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
August 15, 2025
From Bayer
Via Business Wire
OTC Markets Group Welcomes Bayer AG to OTCQX
May 23, 2025
From OTC Markets
Via GlobeNewswire
Bayer Shares Fall 7% As US Court Reconsiders Monsanto PCB Exposure Case
October 09, 2024
Via Talk Markets
Futures Rally Fizzles As Dollar, Yields And Oil Slump
August 17, 2024
Via Talk Markets
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
July 25, 2024
Via Benzinga
Topics Lawsuit
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
June 05, 2024
Via Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Via Benzinga
Topics Data Breach
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Via Benzinga
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
May 02, 2024
Via Benzinga
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
March 19, 2024
Via Benzinga
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
Via Benzinga
Topics Bankruptcy Lawsuit
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
March 05, 2024
Via Benzinga
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
Via Benzinga
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
January 30, 2024
Via Benzinga
Topics Lawsuit

Frequently Asked Questions

Is Bayer Ag Ord publicly traded?
Yes, Bayer Ag Ord is publicly traded.
What exchange does Bayer Ag Ord trade on?
Bayer Ag Ord trades on the OTC Traded
What is the ticker symbol for Bayer Ag Ord?
The ticker symbol for Bayer Ag Ord is BAYZF on the OTC Traded
What is the current price of Bayer Ag Ord?
The current price of Bayer Ag Ord is 31.07
When was Bayer Ag Ord last traded?
The last trade of Bayer Ag Ord was at 10/31/25 01:12 PM ET
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap